Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01487954 · ClinicalTrials.gov registry record · Phase 2
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01487954 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 45 participants.
The verdict
NCT01487954, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
This phase II trial is studying how well alkaline water works in reducing skin toxicity in women with breast cancer undergoing radiation therapy. Alkaline water may reduce radiation therapy-related skin toxicity in patients with breast cancer.
Interventions
- DIETARY_SUPPLEMENT alkaline water
- DIETARY_SUPPLEMENT distilled water
- RADIATION external beam radiation therapy (EBRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01487954
The ClinicalTrials.gov registry entry for NCT01487954 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which alkaline water is the first listed.
NCT01487954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01487954 about?
NCT01487954 is a clinical study titled "Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy". This phase II trial is studying how well alkaline water works in reducing skin toxicity in women with breast cancer undergoing radiation therapy. Alkaline water may reduce radiation therapy-related skin toxicity in patients with breast cancer.
What is the current status of trial NCT01487954?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01487954?
The interventions under investigation include: alkaline water (DIETARY_SUPPLEMENT), distilled water (DIETARY_SUPPLEMENT), external beam radiation therapy (EBRT) (RADIATION).
Who is sponsoring clinical trial NCT01487954?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.